Edgestream Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,499
Closed -$409K 1053
2026
Q1
$409K Sell
2,499
-1,617
-39% -$249K 0.01% 763
2025
Q4
$716K Buy
+4,116
New +$751K 0.02% 750
2025
Q3
Sell
-4,265
Closed -$429K 970
2025
Q2
$429K Buy
+4,265
New +$326K 0.01% 751
2025
Q1
Sell
-43,619
Closed -$3.01M 934
2024
Q4
$3.01M Buy
43,619
+40,369
+1,242% +$2.91M 0.13% 310
2024
Q3
$237K Sell
3,250
-4,805
-60% -$355K 0.01% 791
2024
Q2
$540K Buy
+8,055
New +$312K 0.03% 656
2024
Q1
Sell
-11,758
Closed -$364K 911
2023
Q4
$364K Buy
+11,758
New +$305K 0.03% 675
2022
Q4
Sell
-73,982
Closed -$1.59M 564
2022
Q3
$1.59M Buy
73,982
+11,651
+19% +$279K 0.12% 223
2022
Q2
$1.23M Buy
62,331
+18,804
+43% +$394K 0.1% 282
2022
Q1
$1.02M Sell
43,527
-79,410
-65% -$1.85M 0.08% 325
2021
Q4
$3.35M Sell
122,937
-62,578
-34% -$1.79M 0.21% 146
2021
Q3
$5.11M Sell
185,515
-176,816
-49% -$4.64M 0.32% 105
2021
Q2
$10.3M Buy
+362,331
New +$10.8M 0.61% 37

Other funds holding INSM

Edgestream Partners's INSM Position: Q2 2026 in Review

Edgestream Partners sold out of Insmed (INSM) in Q2 2026, closing a stake of 2,499 shares — an estimated $409K sold.

Edgestream Partners first reported a position in INSM in Q2 2021 and held it in 13 quarters. The position peaked at $10.3M in Q2 2021. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Edgestream Partners reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Edgestream Partners sold 2,499 Insmed shares in Q2 2026, an estimated $409K.
  • Edgestream Partners first reported a position in Insmed in Q2 2021 and held it in 13 quarters.
  • Edgestream Partners's Insmed position peaked at $10.3M in Q2 2021.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.